Aristotle University Of Thessaloniki (AUTH)
Ο ρόλος των πολυμορφισμών του γονιδίου της αδιπονουτρίνης στην εκδήλωση και εξέλιξη της ηπατικής στεάτωσης σε παιδιά
Abstract
dc:descriptionINTRODUCTION: Non-alcoholic fatty liver disease (NAFLD) is a significant cause of liver-related morbidity and mortality and the most common cause of chronic liver disease in children. Numerous studies in humans link nonsynonymous genetic polymorphisms (rs738409 and rs2896019) in adiponutrin gene to hepatic triglyceride accumulation (steatosis), inflammation, fibrosis, cirrhosis, and even hepatocellular carcinoma. Adiponutrin has been shown to possess both triacylglycerol lipase and acylglycerol transacylase activities. Considering the morbidity associated with NAFLD in the pediatric population, it is important to identify those children with hepatic steatosis who are at greatest risk for developing progressive liver disease. AIM: The aim of the present study was to determine the association between the rs738409 and rs2896019 SNPs in adiponutrin gene and liver steatosis, the correlation between the SNPs and the laboratory findings and in a subgroup of subjects undergoing a liver biopsy to explore whether the polymorphisms might be associated with the early onset of steatohepatitis. MATERIALS AND METHODS: The study recruited 91 children and adolescents of Greek descent with NAFLD or biopsy-proven NASH, separated in three groups and 91 phenotypically healthy Greek subjects of normal weight (control group) with gender distribution similar to that of the patient group. The portions of PNPLA3 gene containing the polymorphisms were amplified by polymerase chain reaction (PCR) with the usage of specifically designed primers. RESULTS: A significant correlation was shown between the homozygotes of the rs738409 polymorphism (GG genotype) and heterozygotes of the rs2896019 polymorphism (TG genotype) with the development of hepatic steatosis in children and adolescents of Greek origin (p <0.001). The incidence of the genotypes rs738409 GG, rs738409 CG and rs2896019 TG was found to be increased in patients with hepatic steatosis and in patients with lean NAFLD, but not in obese patients. Hepatic steatosis and steatohepatitis were detected to the vast majority (90%) of the rs738409 polymorphism homozygotes. The combined expression of the two polymorphisms (rs738409 and rs2896019), regardless of the combination of heterozygotes and homozygotes, was associated with a lower age of diagnosis of hepatic steatosis in non-obese patients. The rs738409 GG genotype was significantly associated with high AST, ALT, TC, LDL and TG (p <0.001), while the rs2896019 TG genotype was significantly associated only with high levels of ALT (p <0.001). The ROC curve showed the genotypes rs738409 CG and GG of the rs738409 polymorphism and the TG genotype of the rs2896019 polymorphism, in combination with the values of ALT and the HOMA - IR index, in significant predictive ratios markers (AUC=0,998, OR=3477, 95% CI:308,9–39139,6, p<0,0001). CONCLUSIONS: The detection of increased frequency of the rs738409 GG and the rs2896019 TG genotypes in patients with hepatic steatosis and steatohepatitis and the significant difference in ALT, LDL and HOMA – IR index levels compared to healthy people are in accordance with the findings of similar studies conducted in other populations. The tendency of earlier diagnosis of hepatic steatosis and steatohepatitis in carriers of these genotypes, the correlation of the rs2896019 polymorphism with hepatic steatosis in obese and non-obese patients and the combined study of the two polymorphisms (rs738409 and rs2896019) exclusively in a pediatric population constitute a first research approach internationally.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Stasinou, Eleanna
- Στασινού, Ελεάννα
Subjects
dc:subject × 16- Αδιπονουτρίνη
- Ηπατική στεάτωση
- Μη αλκοολική στεατοηπατίτιδα
- PNPLA3
- rs738409
- rs2896019
- Pediatric non alcoholic fatty liver disease (NAFLD)
- Pediatric non-alcoholic steatohepatitis
- Κλινική Ιατρική
- Ιατρική και Επιστήμες Υγείας
- Παιδιατρική, Νεογνολογία και Υγεία του παιδιού
- Ηπατολογία
- Clinical Medicine
- Medical and Health Sciences
- Pediatrics, Perinatology and Child Health
- Hepatology
Rights
dc:rights- Statement dc:rights
-
- BY_NC_ND
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/48704